Sirtex Medical announced today that it received EU MDR certification to market its SIR-Spheres Y-90 resin microspheres and delivery systems. EU MDR authorization enables Woburn, Massachusetts-based Sirtex to kick off a European launch for its Siros delivery system. Siros offers an intuitive, visual and adaptable solution for physicians to administer SIR-Spheres to liver cancer patients. [...]The post Sirtex Medical begins European launch for microsphere delivery system following EU approval appeared first on Drug Delivery Business.
Sirtex is a Massachusetts-based medical device company that develops and markets minimally invasive interventional systems for the treatment of liver cancer.